Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balstilimab, Botensilimab, and AgenT-797 in pMMR Metastatic Colorectal Cancer with Liver Metastases
NCT07550088Phase 2Recruiting
- Sponsor
- Darren Sigal
- Start
- Jun 2026
- Primary completion
- Sep 2028
- Modality
- Vaccines & Immunotherapeutics, Allogeneic CAR-T, Lymphokine-Activated Killer Cells
- Countries
- 1
01
Overview
A Phase 2 trial of balstilimab, botensilimab, agenT-797 in colorectal cancer (CRC), sponsored by Darren Sigal. Started Jun 2026; status: recruiting.
02
Drugs
balstilimabbotensilimabagenT-797
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07550088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07550088.